NICHOLAS GENRICH: Open Payments
NPI 1124645072 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$948 in 42 payments from 18 companies in 2025. Trend: 2023 $926 · 2024 $961 · 2025 $948
Food & beverage: $948
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $214 |
| Inspire Medical Systems, Inc. | 6 | $169 |
| Grifols USA, LLC | 3 | $91 |
| Verona Pharma, Inc. | 4 | $79 |
| GENZYME CORPORATION | 5 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $60 |
| Insmed, Inc. | 3 | $45 |
| Electromed, Inc. | 3 | $32 |
| Amgen Inc. | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: TEZSPIRE, INSPIRE, DUPIXENT, Prolastin-C Liquid, Ohtuvayre, Arikayce, OFEV, SMARTVEST.
Industry payments across NE — which companies pay providers there.
